K. A. WILSON‐LYNCH

Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease

M. Vatn, D. Rachmilewitz, A. Thomson, 1995, Alimentary pharmacology & therapeutics.

A double‐blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy

D. Ettinger, D S Ettinger, P D Eisenberg, 1996, Cancer.